Trials / Conditions / Stage III Diffuse Large B-Cell Lymphoma
Stage III Diffuse Large B-Cell Lymphoma
3 registered clinical trials studyying Stage III Diffuse Large B-Cell Lymphoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell NCT02541565 | University of Washington | Phase 1 |
| Terminated | Pidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission NCT02530125 | Northwestern University | Phase 2 |
| Active Not Recruiting | Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractor NCT01959698 | Roswell Park Cancer Institute | Phase 1 |